ZIKV E anticorps

N° du produit ABIN7383930

Détail du produit anti-ZIKV E anticorps

Antigène: ZIKV E (Zika Virus Envelope (ZIKV E))

Reactivité: Zika Virus (ZIKV)

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp ZIKV E est non-conjugé

Application: Western Blotting (WB)

Specificité: Anti-Zika virus(ZIKV)(strain Zika SPH2015) ZIKV-E/Envelope protein(Domain III) Monoclonal Antibody

Purification: Protein A Affinity

Immunogène: Recombinant ZIKV (strain Zika SPH2015) Envelope protein (Domain III, His Tag), ABIN7198753

Clone: 29

Isotype: IgG

Information d'application

Indications d'application: WB 1:2000-1:10000

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: 0.2 μm filtered solution in PBS

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur ZIKV E

Antigène: ZIKV E (Zika Virus Envelope (ZIKV E))

Autre désignation: ZIKV Envelope Protein (ZIKV E Produits)

Sujet: E,Envelope Protein,Envelope of Zika virus is resposible for receptor binding and membrane. Analysis of the envelope protein of Zika, from Brazilian Zika SPH215 (KU321639), indicates predicted B and T cell epitopes in peptides that are consistent to those reported for dengue, YFYF and Japanese encephalitis. The envelope Domain II B cell epitope, to which much dengue non-neutralizing cross reaction is attributed, is also conserved also in Zika virus, consistent with prior field observations of cross reactivity with dengue and YF. Domain III of the Zika envelope protein, likely the main specific neutralizing domain, is distinct from recent Brazilian dengue isolates and a recent Peruvian YF isolate (GQ379163), 76 % of possible major histocompatibility complex class (MHC) I and MHC II binding peptides and potential B cell linear epitopes are unique to Zika virus.